Jared Whitlock


Email: jwhitlock@sdbj.com
Phone: 858-634-4636 Extension: 3130

Recent Stories

Every Detail Matters in Hospital Seismic Retrofit

CONSTRUCTION: Difficulties Abound in Medical Environment

Hospital earthquake planning has kept firms in San Diego like Degenkolb Engineers busy in recent years, the result of seismic retrofit deadlines drawing nearer.

Tease photo

ResMed Reports 13 Percent Revenue Increase in Q2

The San Diego company that makes devices and software for sleep issues reported that revenue rose to $601.3 million in the second quarter, a 13 percent year-over-year increase.

Scripps Health to Pay $1.5M in Settlement Over Improper Billing Claims

Scripps Health will pay $1.5 million to settle allegations related to improper billing for physical therapy services, according to the Justice Department.

Salk Partners with Indiviumed

The Salk Institute in San Diego has entered into a multi-year partnership with the cancer research company Indivumed, with the goal of turning research into medical applications.

Illumina to Open Up Market With More Affordable Sequencing

For Illumina, a fairly big announcement recently stemmed from a relatively compact box.

Tease photo

Luna DNA Seeks to Blaze New Trail to Data

BIOTECH: Co. to Use Blockchain, Cryptocurrency to Build Database

Dawn Barry recently came on board as president of the startup led by former Illumina executives like herself.

Tease photo

UC San Diego Health, Eisenhower Health Deal Expands Cancer Services

The agreement will expand cancer clinical trials and treatment options in the Coachella Valley.

Edico Brings Its Speed, Capacity to the Clinic

BIOTECH: Platform Interprets Genetic Data for Targeted Cures

The falling cost of sequencing genomes will generate a data tsunami. Edico Genome stands to make sense of much of it.

Tease photo

UnitedHealthcare Taps DexCom for Diabetes Management

Dexcom’s technology consists of a sensor that reads glucose levels just beneath the skin.

ERs Try Senior Focus For Proactive Medicine

HEALTH: Aim Is to Prevent Likely Problems, Cut Costs

Amid an aging population, San Diego hospitals have developed senior-focused emergency department services to improve care, with an eye toward their bottom lines.

Tease photo

Armed With $100M, Former Receptos Executives Launch New Biotech

In 2015, San Diego’s Receptos sold to Celgene for $7.2 billion. Rather than take it easy or go their separate ways, two Receptos’ executives immediately talked of getting the band back together.

Tease photo

DexCom Reports Big Increase in Q4 Revenue

The glucose monitoring company's unaudited revenue was $218 million during quarter ending Dec. 31.

Celgene to Buy Impact Biomedicines in $7B Deal

Impact Biomedicines was formed around reviving fedratinib, a drug intended to treat a bone marrow disorder and blood cancer.

Ziyen Energy Wins Drilling Contract

The company, formed in 2017, is focused on advanced oil extraction methods.

Arcturus Therapeutics, CureVac Announce Collaboration

The companies' first joint therapy will target a genetic disease marked by ammonia accumulating in the blood.

Illumina, KingMed Partner to Develop Sequencing Technology for China

Illumina called the collaboration a “significant step” toward China Food and Drug Administration review and approval.

Look Ahead: Illumina Aims to Be ‘More Clinical, More Global, and More Digital’

After dominating the research market, genomics giant Illumina set its sights on clinics.

Tease photo

Look Ahead: NuVasive Set to Expand Its Footprint, Increase Its Staff

NuVasive is poised to keep expanding into 2018, from its balance sheet to its headquarters.

Tease photo

Former Receptos Executives Launch New Co. With $100M

Faheem Hasnain and Sheila Gujrathi — former executives of Receptos — have launched a new San Diego biopharmaceutical company...

Some Health Care Cos. See Peril in Net Neutrality Repeal

TECH: Companies Fear Increase in Costs; Others Dismiss Concerns

The repeal of net neutrality regulations drew opposition from big tech players like Google and Netflix. Also fearing impacts of the move: some San Diego health care businesses.

Tease photo

Medtech Cos. Look to Derail Device Tax

LAW: Cos. Claim ACA Tax Damages Hiring and R&D

Carlsbad’s Ra Medical Systems is among the medtech companies that say the return of a 2.3 percent excise tax on medical devices sold in the U.S. threatens expansion and hiring plans.

Tease photo

Look Ahead: Dexcom Plots Strategy for Competitive and Innovative Sector

For Dexcom Inc., September brought unwelcome news. As one analyst put it, “The phantom that has been chasing Dexcom has materialized.”

Tease photo

Tandem Diabetes Care Increases S.D. Manufacturing Space

The company’s new 50,000-square-foot facility on Barnes Canyon Road recently became fully operational.

Cannabis-Derived Drug Granted Priority Review

Greenwich Biosciences developed epidolex, a treatment for seizures in two rare, severe childhood-onset epilepsy disorders.

Preparing For Pot

ECONOMY: From Land to Law to Labs, Marijuana Sales Bring Changes, Opportunities

Inside a 1,000-square-foot room, yellow incandescent light filters down on leafy green marijuana plants in neat rows. Soon, plants and lighting will be added vertically — like a double-decker bus — so operator Outco can increase production more than twofold.

Tease photo

Organovo’s 3D Bioprinted Tissue Treatment Receives Orphan Drug Designation

Organovo designs and creates functional, three-dimensional human tissues for use in drug discovery, clinical development and therapeutic applications.

Palomar Nurses, Caregivers Ratify Contract

HEALTH: Four-Year Deal Brings Retroactive Pay Increases

Both nurse and caregiver unions at Palomar Health recently voted to approve four-year deals with management after seven months of working without a contract.

2017 Newsmakers: Win, Lose or Draw, Ionis Shows It Is a Top Competitor

2017 Newsmakers

In 2017, Carlsbad’s Ionis Pharmaceuticals basked in the success of a drug it developed to treat spinal muscular atrophy in infants.

Tease photo

2017 Newsmakers: Tocagen Advances Cancer Fight with IPO, Breakthrough Designation

2017 Newsmakers

Tocagen brought on Martin “Marty” Duvall as CEO more than a year ago to commercialize its anti-cancer therapies. In 2017, the company marked several milestones on that front.

Tease photo

2017 Newsmakers: Hemker Exits After Huge Changes at Palomar Health

2017 Newsmakers

Robert Hemker, long an architect of Palomar Health District’s financial plans, retired in November.

Tease photo

Palomar Health Nurses, Caregivers Ratify 4-Year Contracts

Under the agreements, 3,000 employees received a retroactive pay raise.

2017 Newsmakers: Sempra Leader So Far Plays Right Cards in Texas

2017 Newsmakers

Besting Warren Buffett is a tall order. Under CEO Debra Reed, Sempra did just that.

Tease photo

Nobel Laureate to Retire From Salk Institute

Pioneering molecular biologist, Elizabeth Blackburn was named Salk’s president in November 2015.

Ionis and Biogen Expand Partnership

Carlsbad’s Ionis Pharmaceuticals and Biogen have expanded their collaboration to identify new drug candidates for the treatment of spinal muscular atrophy (SMA).

New Owner Brings New Strategy for Proton Therapy Center

MEDICINE: It Will Seek Closer Ties With UCSD Health, Bolster Marketing

The region’s first and only proton therapy center has relaunched under new ownership and management after a chapter 11 bankruptcy filing protection last spring.

Tease photo

Sirenas LLC Lands Second Bill & Melinda Gates Foundation Grant

The marine-centric biotech, which has now secured $1.68 million, will use the money to discover potential therapies to treat infectious diseases.

Palomar Health Reaches Tentative Deals with Nurses, Caregivers

The agreements, which cover more than 3,000 employees who are seven months into working without a contract, must still be ratified.

Bridgepoint Is on Both Defense and Offense

EDUCATION: School Faces Lawsuit, Changes Marketing

In 2010, for-profit Bridgepoint Education moved to a prominent downtown San Diego high-rise. Its name and logo affixed outside the top floors of 600 B Street symbolized the company’s rapid rise.

Tease photo

Genoptix to Buy Rosetta Genomics for $10M

The deal, expected to close during the first quarter of 2018, was unanimously approved by both companies’ boards.

Executive Q&A Rakesh Patel, Neighborhood Healthcare

In 2002, Rakesh Patel started as a family physician at Neighborhood Healthcare, an organization he now leads.

Tease photo

Renova Therapeutics’ Drug Receives FDA Fast Track Status

The lead product candidate is a gene transfer drug to treat heart disease.

Becoming Part of The (Health) Plan

Wellness Cos. Help Care and Coverage Providers Find Ways to Effectively Reach and Influence Diverse Customer Bases

Swaying rural teens in Arkansas to stay away from chewing tobacco, a habit ingrained in the local culture, is no easy task. Nor is crafting relatable messages for teens on the dangers of prescription painkiller abuse.

Tease photo

Stakeholder Groups Endorse Sempra’s Purchase of Oncor

By April the Public Utility Commission of Texas will decide whether to OK Sempra buying Energy Future Holdings, which owns 80 percent of Oncor.

Tease photo

In Budget Move, Scripps Health to Cut Corporate Services By $30M

HEALTH: It Will Also Restructure Top Hospital Leadership

Scripps Health will cut corporate services by $30 million and replace the chief executive role at its hospitals with a new leadership model, according to media reports.

Tease photo

FERC Approves Sempra’s Oncor Bid

Sempra Energy’s $9.45 billion plan to obtain an ownership interest in Texas energy giant Oncor Electric took another step forward on Dec. 12.

Tease photo

Dart Neuroscience Laying Off 265 Employees, Shuttering Operations

The cessation will take effect Feb. 9.

Athena Names Holly Smithson as CEO

Smithson previously was the vice president of business strategy at the California Life Sciences Association.

Ionis Earns $45M Licensing Fee for Huntington’s Disease Drug

The Carlsbad drugmaker has licensed what’s being called a groundbreaking treatment following promising early trial results.

Halozyme Licensing Deal Could Be Worth Much More Than $40M

San Diego’s Halozyme Therapeutics will receive a $40 million upfront payment, and potentially much more, as part of a collaboration and licensing deal with Alexion Pharmaceuticals.

Metacrine Gets $22 Million in Funding Round, New Board Member

San Diego biotech Metacrine, which is working on drugs for liver and metabolic diseases, has closed a $22 million Series B financing round.